Riboflavin for Crohn's Disease: What the Evidence Shows

Riboflavin for Crohn's disease has moved from theoretical interest to early clinical evidence. In 2020, a dedicated Crohn's-specific trial called RISE-UP found that 100 mg of daily riboflavin (vitamin B2) significantly reduced symptom scores and inflammatory markers in 70 patients over three weeks (1). For many of us living with Crohn's, the idea that a common, inexpensive B vitamin could meaningfully support our treatment is worth understanding - especially when the safety profile is as favorable as riboflavin's.

This article walks through the RISE-UP trial results, how riboflavin may work in the gut, who is most at risk for deficiency, and what you should know before discussing supplementation with your care team.

Key Takeaways

• In the RISE-UP trial, 70 Crohn's patients taking 100 mg riboflavin daily for 3 weeks showed a significant drop in Harvey-Bradshaw Index symptom scores (p less than 0.001) (1)
• Patients with elevated fecal calprotectin (greater than 200 micrograms/g) saw a significant reduction in C-reactive protein (p = 0.010) and increased antioxidant markers (1)
• Riboflavin is anti-inflammatory, antioxidant, and may support beneficial gut bacteria like Faecalibacterium prausnitzii - a butyrate producer often depleted in Crohn's (1)
• RISE-UP had no placebo arm and lasted only 3 weeks, so results are promising but not confirmatory - larger randomized trials are still needed (4)
• Riboflavin is water-soluble with no established upper intake limit, and the most common visible effect at high doses is harmless bright-yellow urine (1)
• Always discuss any new supplement with your gastroenterologist before starting, especially during flares, biologic infusions, or pregnancy

What Is Riboflavin (Vitamin B2) and Why It Matters in Crohn's Disease

Riboflavin is a water-soluble B vitamin that your body uses to run mitochondrial energy production and antioxidant defenses. It works through two active coenzymes - flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) - that are essential for cellular energy metabolism. You may know it simply as vitamin B2, one of the family of B vitamins that includes thiamine (B1) and others that play overlapping roles in keeping the body running smoothly.

The Role of Riboflavin in the Body

FAD and FMN are involved in hundreds of enzymatic reactions. They power the mitochondrial electron transport chain (your cells' energy factory) and help regenerate glutathione, one of the body's most important internal antioxidants. Without adequate riboflavin, both energy production and antioxidant capacity suffer - two systems that are already under strain in chronic inflammatory conditions.

Why Researchers Looked at It for IBD

Three properties of riboflavin made it a compelling candidate for Crohn's research: it is anti-inflammatory, it is an antioxidant, and early evidence suggests it can modulate the gut microbiome (1). Crohn's disease involves chronic inflammation, oxidative stress, and gut dysbiosis - the very three targets riboflavin is thought to influence. That said, it is important to set expectations clearly from the start: riboflavin is a supportive nutrient with early clinical data, not a replacement for biologics, immunomodulators, or any prescribed Crohn's therapy.

The RISE-UP Trial: What Riboflavin Did for Crohn's Patients

The RISE-UP study (Riboflavin Supplementation in Patients with Crohn's Disease) represents the first clinical trial to test riboflavin specifically in Crohn's disease patients. Its results offer concrete data rather than extrapolation from general nutrition science, and that specificity is what makes it worth understanding.

Study Design and Who Took Part

Von Martels and colleagues published the RISE-UP study in the Journal of Crohn's and Colitis in 2020. It was a prospective clinical intervention involving 70 adults with Crohn's disease who took 100 mg of oral riboflavin daily for three weeks (1). The trial was registered on ClinicalTrials.gov as NCT02538354 (4). Patients had varying disease activity levels, and the researchers analyzed outcomes both across the full group and by subgroups based on fecal calprotectin levels - a marker that indicates active gut inflammation.

What Changed After 3 Weeks

The headline result was encouraging: the Harvey-Bradshaw Index (HBI), a standard clinical measure of Crohn's symptom severity, decreased significantly across the full cohort (p less than 0.001) (1). For patients walking around with persistent symptoms like abdominal pain, loose stools, and fatigue, a meaningful HBI reduction in just three weeks is worth noting.

The inflammation results were also notable, though they varied by subgroup. In patients with elevated fecal calprotectin (greater than 200 micrograms/g) - indicating more active intestinal inflammation - C-reactive protein (CRP) fell significantly (p = 0.010) (1). In patients with low fecal calprotectin, the cytokine IL-2 fell significantly (p = 0.010) (1). Across the full cohort, IL-2 dropped as well (p = 0.004) (1).

On the antioxidant side, plasma free thiols - a marker of the body's antioxidant reserve - rose significantly in the high-inflammation subgroup, suggesting that riboflavin helped reduce oxidative stress where it was most needed (1).

These are genuinely promising findings. But honesty demands context: RISE-UP had no placebo arm and enrolled only 70 patients over just three weeks. Without a control group, some of the improvement may reflect placebo effects, regression to the mean, or natural disease fluctuation. These results are hypothesis-generating - they tell us riboflavin is worth studying further, not that it definitively works.

How Riboflavin May Work: Anti-Inflammation, Antioxidants, and Gut Microbes

Understanding the proposed mechanisms helps put the clinical results in perspective and reveals why researchers believe riboflavin may be more than a generic supplement for Crohn's patients.

The Oxidative Stress Angle

Riboflavin's coenzymes (FAD and FMN) feed directly into the mitochondrial electron transport chain and are required to regenerate glutathione - the body's primary intracellular antioxidant. In Crohn's disease, chronic inflammation generates reactive oxygen species that overwhelm antioxidant defenses. The significant rise in plasma free thiols seen in the RISE-UP high-inflammation subgroup provides a plausible biological mechanism: by supporting the antioxidant system at the cofactor level, riboflavin may help restore balance (1).

The Microbiome Angle

The microbiome hypothesis adds another layer. Faecalibacterium prausnitzii, a butyrate-producing anaerobic bacterium that is consistently reduced in Crohn's disease, appears to benefit from riboflavin availability. Preclinical work has suggested that riboflavin can favor this beneficial commensal. As we discussed in our article on butyrate supplementation for Crohn's disease, butyrate is a critical fuel source for colon cells and plays a role in maintaining gut barrier integrity.

A 2021 pilot study by Pham and Steinert in healthy adults found that colon-delivered vitamin B2 shifted microbiome markers, though vitamin C had the largest overall effect on microbial diversity and short-chain fatty acid production (2). Meanwhile, a 2023 commentary in Gastroenterology by Bourgonje reported that IBD patients whose gut microbes had lower riboflavin biosynthesis capacity experienced proinflammatory responses to beta-fructan dietary fibers - suggesting that riboflavin status may help predict who tolerates certain fibers and who does not (3). This hints at the future possibility of personalized adjunct nutrition based on microbiome profiling.

However, we should be careful with the F. prausnitzii claim specifically. In RISE-UP itself, metagenomic sequencing did not show significant taxonomic or diversity changes after three weeks of riboflavin, even though FISH analysis showed decreased Enterobacteriaceae (1). The microbiome story is not yet settled. For a broader look at why gut microbiome diversity matters in Crohn's progression and recovery, we have covered the topic in depth.

Riboflavin Deficiency and Absorption in Crohn's Disease

Even apart from the RISE-UP findings, riboflavin deficiency deserves attention as a standalone nutritional concern for Crohn's patients. The absorption site and the disease itself create a predictable vulnerability.

Why Crohn's Raises Deficiency Risk

Riboflavin is absorbed mainly in the proximal small intestine - the exact region often affected by Crohn's, especially in patients with ileal or upper gastrointestinal involvement. Several factors compound this: reduced dietary intake during flares (when many of us avoid dairy, eggs, leafy greens, and lean meats), malabsorption from inflamed or scarred mucosa, and permanently reduced absorptive surface area after small-bowel resection.

As part of the broader pattern of micronutrient deficiencies in Crohn's disease, riboflavin depletion often coexists with deficiencies in other B vitamins, iron, zinc, and fat-soluble vitamins.

Signs and Testing

Clinical riboflavin deficiency can produce distinctive symptoms: sore or cracked lips (cheilitis), inflamed corners of the mouth (angular stomatitis), a sore red tongue (glossitis), sore throat, and skin changes. These signs overlap with other nutritional deficiencies, so blood testing is essential to confirm.

The reference method for assessing riboflavin status is the erythrocyte glutathione reductase activity coefficient (EGRAC). Urinary riboflavin excretion is also used in some settings. If you notice any of these symptoms, especially after a prolonged flare or bowel resection, raising the question with your gastroenterologist or IBD dietitian is a reasonable first step.

Dosing, Safety, and What Patients Should Know Before Trying It

One of riboflavin's most practical advantages is its favorable safety profile. But dose, context, and communication with your care team still matter.

What Dose Was Studied

The RISE-UP trial used 100 mg of oral riboflavin daily for three weeks in adults with Crohn's disease (1). For comparison, the U.S. Recommended Dietary Allowance is 1.3 mg per day for adult men and 1.1 mg per day for adult women - so the RISE-UP dose was roughly 80 to 90 times higher than the RDA. This is a pharmacologic dose, not a dietary one.

Safety, Side Effects, and Interactions

Riboflavin is water-soluble and has no established tolerable upper intake level, which reflects its overall safety record. The most common visible effect at high doses is bright-yellow urine from unabsorbed vitamin - this is harmless and resolves when supplementation stops. No serious adverse events were flagged in the RISE-UP trial (1).

Practical tips for anyone whose clinician recommends trying riboflavin: take it with food for better absorption, choose reputable brands with third-party testing (look for USP or NSF certification), and avoid mega-dose combination products that pile on stimulants, herbs, or other ingredients unrelated to your nutritional needs.

A final note on self-supplementation: always discuss any new supplement with your gastroenterologist or IBD nurse before starting. This is especially important during flares, while receiving biologic infusions, during pregnancy, or when taking immunomodulators. Riboflavin is low-risk, but shared decision-making with your care team is the standard you deserve.

The Bottom Line: Where Riboflavin Fits in a Crohn's Care Plan

Riboflavin sits in a category that is both promising and incomplete - a low-risk, low-cost nutrient with one Crohn's-specific clinical trial showing real signal, but without the randomized, placebo-controlled confirmation that would make it evidence-based in the strongest sense.

What the Evidence Supports Today

One open-label 70-patient study over three weeks suggests that 100 mg daily riboflavin may help lower inflammatory markers and symptom scores in Crohn's disease (1). The biological mechanisms are plausible: riboflavin supports antioxidant defenses, may reduce oxidative stress, and has theoretical microbiome benefits. Its safety profile is reassuring, with no established upper limit and no serious adverse events in the trial. This makes riboflavin a reasonable topic to raise with your IBD team - not as a treatment, but as a low-risk adjunct worth discussing.

What Is Still Unknown

Researchers still need to answer fundamental questions: What is the optimal dose? Does the benefit last beyond three weeks? Can riboflavin help prevent flares rather than just reduce symptoms during stable disease? And does it work better in specific subgroups - patients with elevated calprotectin, low F. prausnitzii, or ileal disease?

Until those studies happen, the most practical approach is to prioritize riboflavin-rich foods (dairy products, eggs, leafy greens, lean meats, and fortified cereals), get tested if deficiency symptoms appear, and have a shared-decision conversation with your gastroenterologist before starting a 100 mg supplement based on RISE-UP.

Frequently Asked Questions

Is riboflavin safe to take alongside biologics like infliximab or adalimumab?

Riboflavin is a water-soluble vitamin with no known drug interactions with biologic therapies. However, any time you add a supplement while receiving biologic infusions, it is worth informing your IBD team so they can note it in your record and monitor for any unexpected changes in your labs or symptoms (1).

How quickly could I notice a difference from riboflavin supplementation?

In the RISE-UP trial, measurable changes in symptom scores and inflammatory markers appeared within three weeks at 100 mg per day (1). Individual responses vary, and some patients may not notice any perceptible change. Tracking your symptoms in a journal or app can help you and your clinician evaluate whether supplementation is having an effect.

Does riboflavin help with Crohn's-related fatigue?

Riboflavin plays a central role in mitochondrial energy production, and deficiency can contribute to fatigue. If your fatigue partly stems from suboptimal riboflavin status, correcting the deficiency may help. However, Crohn's-related fatigue is multifactorial - inflammation, anemia, other B-vitamin deficiencies, and sleep disruption all contribute. Riboflavin alone is unlikely to resolve it entirely.

Can I get enough riboflavin from food instead of supplements?

For meeting the RDA of 1.1 to 1.3 mg per day, dietary sources are usually sufficient if you tolerate dairy, eggs, leafy greens, lean meats, and fortified cereals. The RISE-UP trial used a pharmacologic dose of 100 mg per day - far above what food alone provides. If your clinician recommends that higher dose based on the research, a supplement would be necessary.

Will riboflavin turn my urine yellow?

Yes. At doses above what the body can absorb, excess riboflavin is excreted in urine, turning it a bright fluorescent yellow. This is harmless, completely normal, and stops when you reduce the dose or stop the supplement. It is actually a sign that your body is safely eliminating what it does not need.

Should I take riboflavin during a flare?

The RISE-UP trial included patients with varying disease activity, and the strongest anti-inflammatory effects were seen in patients with elevated fecal calprotectin - those with more active inflammation (1). That said, adding any supplement during a severe flare should always be discussed with your care team first, as your overall treatment plan may need to be adjusted.

Is riboflavin covered by insurance or available over the counter?

Riboflavin supplements are widely available over the counter at pharmacies and online in most countries, and they are generally inexpensive. Insurance coverage for nutritional supplements varies by country and plan. In many healthcare systems, your clinician can recommend a specific product but it may not be reimbursable. Third-party-tested brands with USP or NSF certification are generally recommended for quality assurance.

References

1. Von Martels JZH, Bourgonje AR, Klaassen MAY, et al. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study]. Journal of Crohn's and Colitis, 2020;14(5):595-607. Read study on PubMed
2. Pham VT, Fehlbaum S, Seifert N, et al. Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome - a pilot study. Gut Microbes, 2021;13(1):1875774. Read study
3. Bourgonje AR. Microbial Riboflavin Biosynthesis Associates With Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients With Inflammatory Bowel Disease? Gastroenterology, 2023;164(2):515-516. Read commentary on PubMed
4. The Effect of Riboflavin in Crohn's Disease (RISE-UP). ClinicalTrials.gov, NCT02538354. View trial registration